Abstract

We performed an individual participant data (IPD) metaanalysis to calculate the recurrence risk of hypertensive disorders of pregnancy (HDP) and recurrence of individual hypertensive syndromes. We performed an electronic literature search for cohort studies that reported on women experiencing HDP and who had a subsequent pregnancy. The principal investigators were contacted and informed of our study; we requested their original study data. The data were merged to form one combined database. The results will be presented as percentages with 95% confidence interval (CI) and odds ratios with 95% CI. Of 94 eligible cohort studies, we obtained IPD of 22 studies, including a total of 99,415 women. Pooled data of 64 studies that used published data (IPD where available) showed a recurrence rate of 18.1% (n=152,213; 95% CI, 17.9-18.3%). In the 22 studies that are included in our IPD, the recurrence rate of a HDP was 20.7% (95% CI, 20.4-20.9%). Recurrence manifested as preeclampsia in 13.8% of the studies (95% CI,13.6-14.1%), gestational hypertension in 8.6% of the studies (95% CI, 8.4-8.8%) and hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome in 0.2% of the studies (95% CI, 0.16-0.25%). The delivery of a small-for-gestational-age child accompanied the recurrent HDP in 3.4% of the studies (95% CI, 3.2-3.6%). Concomitant HELLP syndrome or delivery of a small-for-gestational-age child increased the risk of recurrence of HDP. Recurrence increased with decreasing gestational age at delivery in the index pregnancy. If the HDP recurred, in general it was milder, regarding maximum diastolic blood pressure, proteinuria, the use of oral antihypertensive and anticonvulsive medication, the delivery of a small-for-gestational-age child, premature delivery, and perinatal death. Normotensive women experienced chronic hypertension after pregnancy more often after experiencing recurrence (odds ratio, 3.7; 95% CI, 2.3-6.1). Among women that experience hypertension in pregnancy, the recurrence rate in a next pregnancy is relatively low, and the course of disease is milder for most women with recurrent disease. These reassuring data should be used for shared decision-making in women who consider a new pregnancy after a pregnancy that was complicated by hypertension.

Highlights

  • Hypertensive disorders of pregnancy (HDP) are a common health problem and are the second most common cause of maternal death worldwide, with major intriguing regional differences worldwide [1]

  • We focused on collecting demographic characteristics such as age and Body Mass Index (BMI), cardiovascular risk factors and the clinical syndrome of the index pregnancy

  • Definitions: Hypertensive disorders of pregnancy were defined as gestational hypertension (GH), preeclampsia (PE), superimposed PE or HELLP syndrome

Read more

Summary

Results

Out of 94 eligible cohort studies, we obtained IPD of 22 studies, including a total of 99,415 women. Pooled data of 64 studies using published data (IPD where available) showed a recurrence rate of 18.1% (N=152,213, 95% CI: 17.9 – 18.3). In the 22 studies included in our IPD, the recurrence rate of a HDP was 20.7% (95%CI: 20.4 – 20.9). Recurrence manifested as preeclampsia (PE) in 13.8% (95%CI: 13.6 – 14.1), gestational hypertension (GH) in 8.6% (95%CI: 8.4 – 8.8) and Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome in 0.2% (95%CI: 0.16 – 0.25). The delivery of a small for gestational age (SGA) child accompanied the recurrent HDP in 3.4% (95%CI: 3.2 – 3.6). Concomitant HELLP syndrome or delivery of a SGA child increased the risk of recurrence of HDP. Recurrence increased with decreasing gestational age at delivery in the index pregnancy. Normotensive women developed chronic hypertension after pregnancy more often after experiencing recurrence (OR 3.7 95% CI: 2.3 – 6.1)

Conclusion
INTRODUCTION
MATERIALS AND METHODS
RESULTS
Tables and figures:
Study design
(%) References

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.